Macrophage-mimic shape changeable nanomedicine retained in tumor for multimodal therapy of breast cancer

The current nanomedicines for cancer therapy based on the enhance permeability and retention (EPR) effect remain insufficient to satisfy the clinical need, and the challenges hindering nanomedicines delivery should be conquered for strong therapeutic efficacy. To address these problems, a membrane-c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of controlled release 2020-05, Vol.321, p.589-601
Hauptverfasser: Liu, Rui, An, Yang, Jia, Wenfeng, Wang, Yushan, Wu, Yue, Zhen, Yonghuan, Cao, Jun, Gao, Huile
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 601
container_issue
container_start_page 589
container_title Journal of controlled release
container_volume 321
creator Liu, Rui
An, Yang
Jia, Wenfeng
Wang, Yushan
Wu, Yue
Zhen, Yonghuan
Cao, Jun
Gao, Huile
description The current nanomedicines for cancer therapy based on the enhance permeability and retention (EPR) effect remain insufficient to satisfy the clinical need, and the challenges hindering nanomedicines delivery should be conquered for strong therapeutic efficacy. To address these problems, a membrane-coated laser-responsive shape changeable nanomedicine, I-P@NPs@M, is reported. The covering macrophage membrane promotes the circulation and tumor targeting of nanomedicines. Then the chlorin e6 (Ce6) in I-P@NPs@M can convert 650 nm laser into reactive oxygen species (ROS) to trigger the spherical micelles changing into nanofibers for strong retention in tumor region, consequently the linear nanofibers long locate and sustainably release drugs. On the other hand, the ROS not only directly kills tumor cells by photodynamic therapy but stimulates the dimeric paclitaxel (PTX) generating monomeric PTX. The combinational chemo- photodynamic therapy heavily suppresses tumor growth and inducing immunogenic cell death, which is synergistic with Indoximod (IND) inhibiting the IDO pathway to activate immune response for immunotherapy. By chemotherapy, photodynamic therapy and immunotherapy gathering, the treatment of I-P@NPs@M + laser shows the best antitumor effect, resulting in 85.27 ± 12.80% suppression of breast cancer in mice model, and also remarkably inhibits lung metastasis. The macrophage membrane-coated shape changeable nanomedicine, I-P@NPs@M, successively overcomes the challenges of blood circulation, tumor targeting, intratumoral distribution, cellular internalization and drug release, fulfilling multimodal therapy by specific and effective chemotherapy, photodynamic therapy and immunotherapy, which strongly suppress the growth of breast cancer tumor and inhibit lung metastasis on the mice model. [Display omitted] •Successively overcome the barriers lying on the drug delivery to breast cancer tumor.•Combine membrane coating and shape change for enhancing biodistribution.•Utilize dimeric drugs for the good loading and specific drug activities.•Conjugate the multimodal therapy in order for strong efficacy.
doi_str_mv 10.1016/j.jconrel.2020.02.043
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2369880845</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168365920301322</els_id><sourcerecordid>2369880845</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-26d0b1200e454cf268564b67d7592b8414a9969b4e20fc513c0d11cf2d445d13</originalsourceid><addsrcrecordid>eNqFkD1v2zAQhokiReOk_QktOGaReqRIWZyKwEiaAi66ZCco8hTRkESVlAL435eGnawdDrc87308hHxlUDJg9fdDebBhijiUHDiUwEsQ1QeyYc22KoRS8opsMtcUVS3VNblJ6QAAshLbT-S64owJUGxD-t_GxjD35gWL0Y_e0tSbGantzfSCph2QTmYKIzpv_YQ04mJyd9RPdFnHEGmXa1yHxY_BmYEuPUYzH2noaBvRpIVaM1mMn8nHzgwJv1z6LXl-fHjePRX7Pz9_7e73hc2HLgWvHbSMA6CQwna8bmQt2nrrtlLxthFMGKVq1Qrk0FnJKguOsQw6IaRj1S25O4-dY_i7Ylr06JPFYTAThjVpXtWqaaARMqPyjGYBKUXs9Bz9aOJRM9Anx_qgL471ybEGrrPjnPt2WbG22ct76k1qBn6cAcx_vnqMOlmPWYLzEe2iXfD_WfEPpBGQnw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2369880845</pqid></control><display><type>article</type><title>Macrophage-mimic shape changeable nanomedicine retained in tumor for multimodal therapy of breast cancer</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Liu, Rui ; An, Yang ; Jia, Wenfeng ; Wang, Yushan ; Wu, Yue ; Zhen, Yonghuan ; Cao, Jun ; Gao, Huile</creator><creatorcontrib>Liu, Rui ; An, Yang ; Jia, Wenfeng ; Wang, Yushan ; Wu, Yue ; Zhen, Yonghuan ; Cao, Jun ; Gao, Huile</creatorcontrib><description>The current nanomedicines for cancer therapy based on the enhance permeability and retention (EPR) effect remain insufficient to satisfy the clinical need, and the challenges hindering nanomedicines delivery should be conquered for strong therapeutic efficacy. To address these problems, a membrane-coated laser-responsive shape changeable nanomedicine, I-P@NPs@M, is reported. The covering macrophage membrane promotes the circulation and tumor targeting of nanomedicines. Then the chlorin e6 (Ce6) in I-P@NPs@M can convert 650 nm laser into reactive oxygen species (ROS) to trigger the spherical micelles changing into nanofibers for strong retention in tumor region, consequently the linear nanofibers long locate and sustainably release drugs. On the other hand, the ROS not only directly kills tumor cells by photodynamic therapy but stimulates the dimeric paclitaxel (PTX) generating monomeric PTX. The combinational chemo- photodynamic therapy heavily suppresses tumor growth and inducing immunogenic cell death, which is synergistic with Indoximod (IND) inhibiting the IDO pathway to activate immune response for immunotherapy. By chemotherapy, photodynamic therapy and immunotherapy gathering, the treatment of I-P@NPs@M + laser shows the best antitumor effect, resulting in 85.27 ± 12.80% suppression of breast cancer in mice model, and also remarkably inhibits lung metastasis. The macrophage membrane-coated shape changeable nanomedicine, I-P@NPs@M, successively overcomes the challenges of blood circulation, tumor targeting, intratumoral distribution, cellular internalization and drug release, fulfilling multimodal therapy by specific and effective chemotherapy, photodynamic therapy and immunotherapy, which strongly suppress the growth of breast cancer tumor and inhibit lung metastasis on the mice model. [Display omitted] •Successively overcome the barriers lying on the drug delivery to breast cancer tumor.•Combine membrane coating and shape change for enhancing biodistribution.•Utilize dimeric drugs for the good loading and specific drug activities.•Conjugate the multimodal therapy in order for strong efficacy.</description><identifier>ISSN: 0168-3659</identifier><identifier>EISSN: 1873-4995</identifier><identifier>DOI: 10.1016/j.jconrel.2020.02.043</identifier><identifier>PMID: 32114091</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Breast Neoplasms - drug therapy ; Cell Line, Tumor ; Humans ; IDO pathway ; Immunogenic cell death ; Immunotherapy ; Macrophage membrane ; Macrophages ; Mice ; Nanomedicine ; Nanoparticles ; Photochemotherapy ; Shape change</subject><ispartof>Journal of controlled release, 2020-05, Vol.321, p.589-601</ispartof><rights>2020</rights><rights>Copyright © 2020. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-26d0b1200e454cf268564b67d7592b8414a9969b4e20fc513c0d11cf2d445d13</citedby><cites>FETCH-LOGICAL-c365t-26d0b1200e454cf268564b67d7592b8414a9969b4e20fc513c0d11cf2d445d13</cites><orcidid>0000-0002-5355-7238</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jconrel.2020.02.043$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32114091$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Rui</creatorcontrib><creatorcontrib>An, Yang</creatorcontrib><creatorcontrib>Jia, Wenfeng</creatorcontrib><creatorcontrib>Wang, Yushan</creatorcontrib><creatorcontrib>Wu, Yue</creatorcontrib><creatorcontrib>Zhen, Yonghuan</creatorcontrib><creatorcontrib>Cao, Jun</creatorcontrib><creatorcontrib>Gao, Huile</creatorcontrib><title>Macrophage-mimic shape changeable nanomedicine retained in tumor for multimodal therapy of breast cancer</title><title>Journal of controlled release</title><addtitle>J Control Release</addtitle><description>The current nanomedicines for cancer therapy based on the enhance permeability and retention (EPR) effect remain insufficient to satisfy the clinical need, and the challenges hindering nanomedicines delivery should be conquered for strong therapeutic efficacy. To address these problems, a membrane-coated laser-responsive shape changeable nanomedicine, I-P@NPs@M, is reported. The covering macrophage membrane promotes the circulation and tumor targeting of nanomedicines. Then the chlorin e6 (Ce6) in I-P@NPs@M can convert 650 nm laser into reactive oxygen species (ROS) to trigger the spherical micelles changing into nanofibers for strong retention in tumor region, consequently the linear nanofibers long locate and sustainably release drugs. On the other hand, the ROS not only directly kills tumor cells by photodynamic therapy but stimulates the dimeric paclitaxel (PTX) generating monomeric PTX. The combinational chemo- photodynamic therapy heavily suppresses tumor growth and inducing immunogenic cell death, which is synergistic with Indoximod (IND) inhibiting the IDO pathway to activate immune response for immunotherapy. By chemotherapy, photodynamic therapy and immunotherapy gathering, the treatment of I-P@NPs@M + laser shows the best antitumor effect, resulting in 85.27 ± 12.80% suppression of breast cancer in mice model, and also remarkably inhibits lung metastasis. The macrophage membrane-coated shape changeable nanomedicine, I-P@NPs@M, successively overcomes the challenges of blood circulation, tumor targeting, intratumoral distribution, cellular internalization and drug release, fulfilling multimodal therapy by specific and effective chemotherapy, photodynamic therapy and immunotherapy, which strongly suppress the growth of breast cancer tumor and inhibit lung metastasis on the mice model. [Display omitted] •Successively overcome the barriers lying on the drug delivery to breast cancer tumor.•Combine membrane coating and shape change for enhancing biodistribution.•Utilize dimeric drugs for the good loading and specific drug activities.•Conjugate the multimodal therapy in order for strong efficacy.</description><subject>Animals</subject><subject>Breast Neoplasms - drug therapy</subject><subject>Cell Line, Tumor</subject><subject>Humans</subject><subject>IDO pathway</subject><subject>Immunogenic cell death</subject><subject>Immunotherapy</subject><subject>Macrophage membrane</subject><subject>Macrophages</subject><subject>Mice</subject><subject>Nanomedicine</subject><subject>Nanoparticles</subject><subject>Photochemotherapy</subject><subject>Shape change</subject><issn>0168-3659</issn><issn>1873-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkD1v2zAQhokiReOk_QktOGaReqRIWZyKwEiaAi66ZCco8hTRkESVlAL435eGnawdDrc87308hHxlUDJg9fdDebBhijiUHDiUwEsQ1QeyYc22KoRS8opsMtcUVS3VNblJ6QAAshLbT-S64owJUGxD-t_GxjD35gWL0Y_e0tSbGantzfSCph2QTmYKIzpv_YQ04mJyd9RPdFnHEGmXa1yHxY_BmYEuPUYzH2noaBvRpIVaM1mMn8nHzgwJv1z6LXl-fHjePRX7Pz9_7e73hc2HLgWvHbSMA6CQwna8bmQt2nrrtlLxthFMGKVq1Qrk0FnJKguOsQw6IaRj1S25O4-dY_i7Ylr06JPFYTAThjVpXtWqaaARMqPyjGYBKUXs9Bz9aOJRM9Anx_qgL471ybEGrrPjnPt2WbG22ct76k1qBn6cAcx_vnqMOlmPWYLzEe2iXfD_WfEPpBGQnw</recordid><startdate>20200510</startdate><enddate>20200510</enddate><creator>Liu, Rui</creator><creator>An, Yang</creator><creator>Jia, Wenfeng</creator><creator>Wang, Yushan</creator><creator>Wu, Yue</creator><creator>Zhen, Yonghuan</creator><creator>Cao, Jun</creator><creator>Gao, Huile</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5355-7238</orcidid></search><sort><creationdate>20200510</creationdate><title>Macrophage-mimic shape changeable nanomedicine retained in tumor for multimodal therapy of breast cancer</title><author>Liu, Rui ; An, Yang ; Jia, Wenfeng ; Wang, Yushan ; Wu, Yue ; Zhen, Yonghuan ; Cao, Jun ; Gao, Huile</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-26d0b1200e454cf268564b67d7592b8414a9969b4e20fc513c0d11cf2d445d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Breast Neoplasms - drug therapy</topic><topic>Cell Line, Tumor</topic><topic>Humans</topic><topic>IDO pathway</topic><topic>Immunogenic cell death</topic><topic>Immunotherapy</topic><topic>Macrophage membrane</topic><topic>Macrophages</topic><topic>Mice</topic><topic>Nanomedicine</topic><topic>Nanoparticles</topic><topic>Photochemotherapy</topic><topic>Shape change</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Rui</creatorcontrib><creatorcontrib>An, Yang</creatorcontrib><creatorcontrib>Jia, Wenfeng</creatorcontrib><creatorcontrib>Wang, Yushan</creatorcontrib><creatorcontrib>Wu, Yue</creatorcontrib><creatorcontrib>Zhen, Yonghuan</creatorcontrib><creatorcontrib>Cao, Jun</creatorcontrib><creatorcontrib>Gao, Huile</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of controlled release</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Rui</au><au>An, Yang</au><au>Jia, Wenfeng</au><au>Wang, Yushan</au><au>Wu, Yue</au><au>Zhen, Yonghuan</au><au>Cao, Jun</au><au>Gao, Huile</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Macrophage-mimic shape changeable nanomedicine retained in tumor for multimodal therapy of breast cancer</atitle><jtitle>Journal of controlled release</jtitle><addtitle>J Control Release</addtitle><date>2020-05-10</date><risdate>2020</risdate><volume>321</volume><spage>589</spage><epage>601</epage><pages>589-601</pages><issn>0168-3659</issn><eissn>1873-4995</eissn><abstract>The current nanomedicines for cancer therapy based on the enhance permeability and retention (EPR) effect remain insufficient to satisfy the clinical need, and the challenges hindering nanomedicines delivery should be conquered for strong therapeutic efficacy. To address these problems, a membrane-coated laser-responsive shape changeable nanomedicine, I-P@NPs@M, is reported. The covering macrophage membrane promotes the circulation and tumor targeting of nanomedicines. Then the chlorin e6 (Ce6) in I-P@NPs@M can convert 650 nm laser into reactive oxygen species (ROS) to trigger the spherical micelles changing into nanofibers for strong retention in tumor region, consequently the linear nanofibers long locate and sustainably release drugs. On the other hand, the ROS not only directly kills tumor cells by photodynamic therapy but stimulates the dimeric paclitaxel (PTX) generating monomeric PTX. The combinational chemo- photodynamic therapy heavily suppresses tumor growth and inducing immunogenic cell death, which is synergistic with Indoximod (IND) inhibiting the IDO pathway to activate immune response for immunotherapy. By chemotherapy, photodynamic therapy and immunotherapy gathering, the treatment of I-P@NPs@M + laser shows the best antitumor effect, resulting in 85.27 ± 12.80% suppression of breast cancer in mice model, and also remarkably inhibits lung metastasis. The macrophage membrane-coated shape changeable nanomedicine, I-P@NPs@M, successively overcomes the challenges of blood circulation, tumor targeting, intratumoral distribution, cellular internalization and drug release, fulfilling multimodal therapy by specific and effective chemotherapy, photodynamic therapy and immunotherapy, which strongly suppress the growth of breast cancer tumor and inhibit lung metastasis on the mice model. [Display omitted] •Successively overcome the barriers lying on the drug delivery to breast cancer tumor.•Combine membrane coating and shape change for enhancing biodistribution.•Utilize dimeric drugs for the good loading and specific drug activities.•Conjugate the multimodal therapy in order for strong efficacy.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>32114091</pmid><doi>10.1016/j.jconrel.2020.02.043</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-5355-7238</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0168-3659
ispartof Journal of controlled release, 2020-05, Vol.321, p.589-601
issn 0168-3659
1873-4995
language eng
recordid cdi_proquest_miscellaneous_2369880845
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Animals
Breast Neoplasms - drug therapy
Cell Line, Tumor
Humans
IDO pathway
Immunogenic cell death
Immunotherapy
Macrophage membrane
Macrophages
Mice
Nanomedicine
Nanoparticles
Photochemotherapy
Shape change
title Macrophage-mimic shape changeable nanomedicine retained in tumor for multimodal therapy of breast cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T15%3A17%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Macrophage-mimic%20shape%20changeable%20nanomedicine%20retained%20in%20tumor%20for%20multimodal%20therapy%20of%20breast%20cancer&rft.jtitle=Journal%20of%20controlled%20release&rft.au=Liu,%20Rui&rft.date=2020-05-10&rft.volume=321&rft.spage=589&rft.epage=601&rft.pages=589-601&rft.issn=0168-3659&rft.eissn=1873-4995&rft_id=info:doi/10.1016/j.jconrel.2020.02.043&rft_dat=%3Cproquest_cross%3E2369880845%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2369880845&rft_id=info:pmid/32114091&rft_els_id=S0168365920301322&rfr_iscdi=true